C8 MediSensors Gets $24M
San Jose-based C8 MediSEnsors, a developer of noninvasive, continuous glucose monitoring devices for diabetics, said today that it has raised $24M in a Series C preferred stock financing. The funding came from GE's healthmagination Fund, along with both existing and other new investors. C8 MediSensors did not detail the names of its other investors in this round.
posted on Thursday, December 1, 2011 (Link to more information)
Related companies:
C8 Medisensors
Related stories:
> C8 Medisensors Finds $19M For Glucose Monitors
silicontap.com Home